Stefano Barlati1,2, Gabriele Nibbio1, Antonio Vita1,2. 1. Department of Clinical and Experimental Sciences, University of Brescia. 2. Department of Mental Health and Addiction Services, ASST Spedali Civili of Brescia, Brescia, Italy.
Abstract
PURPOSE OF REVIEW: The coronavirus disease 19 (COVID-19) pandemic is having a critical impact on healthcare systems across the world, as well as on mental health in the general population; however, evidence regarding the impact of the COVID-19 pandemic on people living with schizophrenia and on the onset of psychotic symptoms is currently emerging. RECENT FINDINGS: People living with schizophrenia are at an increased risk of COVID-19 and present worse COVID-19-related outcomes, including mortality. They show low levels of information and of concern regarding the possibility of contagion and infection but presented substantially stable levels of psychotic symptoms and even increased subjective well being during the pandemic. SARS-CoV-2, as well as the prolonged social isolation and the spread of misinformation, appear to be responsible in some cases for the onset of psychotic symptoms. SUMMARY: Clinicians should inform and educate their patients on the risks related to SARS-CoV-2 infection and COVID-19 and on the precautions that they should adopt to avoid contagion. Particular attention should be devoted to maintaining the continuity of care, especially in frail patients. Telemedicine might represent a valid support, but face-to-face visits in some cases remain essential. The hypothesis of a direct role of viral infection on the onset of psychotic disorders is currently debated, as viral involvement of central nervous system appears to be rather infrequent in COVID-19.
PURPOSE OF REVIEW: The coronavirus disease 19 (COVID-19) pandemic is having a critical impact on healthcare systems across the world, as well as on mental health in the general population; however, evidence regarding the impact of the COVID-19 pandemic on people living with schizophrenia and on the onset of psychotic symptoms is currently emerging. RECENT FINDINGS: People living with schizophrenia are at an increased risk of COVID-19 and present worse COVID-19-related outcomes, including mortality. They show low levels of information and of concern regarding the possibility of contagion and infection but presented substantially stable levels of psychotic symptoms and even increased subjective well being during the pandemic. SARS-CoV-2, as well as the prolonged social isolation and the spread of misinformation, appear to be responsible in some cases for the onset of psychotic symptoms. SUMMARY: Clinicians should inform and educate their patients on the risks related to SARS-CoV-2 infection and COVID-19 and on the precautions that they should adopt to avoid contagion. Particular attention should be devoted to maintaining the continuity of care, especially in frail patients. Telemedicine might represent a valid support, but face-to-face visits in some cases remain essential. The hypothesis of a direct role of viral infection on the onset of psychotic disorders is currently debated, as viral involvement of central nervous system appears to be rather infrequent in COVID-19.
Authors: Carmen Moreno; Til Wykes; Silvana Galderisi; Merete Nordentoft; Nicolas Crossley; Nev Jones; Mary Cannon; Christoph U Correll; Louise Byrne; Sarah Carr; Eric Y H Chen; Philip Gorwood; Sonia Johnson; Hilkka Kärkkäinen; John H Krystal; Jimmy Lee; Jeffrey Lieberman; Carlos López-Jaramillo; Miia Männikkö; Michael R Phillips; Hiroyuki Uchida; Eduard Vieta; Antonio Vita; Celso Arango Journal: Lancet Psychiatry Date: 2020-07-16 Impact factor: 27.083
Authors: Sarah L Kopelovich; Maria Monroe-DeVita; Benjamin E Buck; Carolyn Brenner; Lorna Moser; L Fredrik Jarskog; Steve Harker; Lydia A Chwastiak Journal: Community Ment Health J Date: 2020-06-19
Authors: Andres F Correa-Palacio; Daniel Hernandez-Huerta; Jorge Gómez-Arnau; Carmen Loeck; Irene Caballero Journal: Psychiatry Res Date: 2020-05-21 Impact factor: 3.222
Authors: Risha Govind; Daniela Fonseca de Freitas; Megan Pritchard; Richard D Hayes; James H MacCabe Journal: Br J Psychiatry Date: 2021-07 Impact factor: 9.319
Authors: Elena M D Schönthaler; Nina Dalkner; Michaela Ratzenhofer; Eva Fleischmann; Frederike T Fellendorf; Susanne A Bengesser; Armin Birner; Alexander Maget; Melanie Lenger; Martina Platzer; Robert Queissner; Adelina Tmava-Berisha; Christina Berndt; Julia Martini; Michael Bauer; Jon Dyg Sperling; Maj Vinberg; Eva Z Reininghaus Journal: Int J Environ Res Public Health Date: 2022-06-22 Impact factor: 4.614
Authors: Antonio José Sánchez-Guarnido; Valentina Lucena; Aurora Torrent; Laura Bosa; Virginia Martinez-López; Ana Cuartiles-Berenguer; Iolanda Batalla Journal: Front Psychol Date: 2022-03-10